Author Correction: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme.
- DOI
- 10.1038/s43856-026-01895-x
- Published
- 2026 Sep 21
- Container
- Communications medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s43856-026-01895-x,
title = {Author Correction: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme.},
author = {Angom RS and Rachamala HK and Nakka NMR and Madamsetty VS and Suarez-Meade P and Fernandez-Gil BI and Kulkarni T and Weil RM and Dutta S and Wang E and Bhattacharya S and Pal K and Quinones-Hinojosa A and Mukhopadhyay D},
year = {2026},
journal = {Communications medicine},
doi = {10.1038/s43856-026-01895-x},
url = {https://doi.org/10.1038/s43856-026-01895-x}
}RIS
TY - JOUR TI - Author Correction: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme. AU - Angom RS AU - Rachamala HK AU - Nakka NMR AU - Madamsetty VS AU - Suarez-Meade P AU - Fernandez-Gil BI AU - Kulkarni T AU - Weil RM AU - Dutta S AU - Wang E AU - Bhattacharya S AU - Pal K AU - Quinones-Hinojosa A AU - Mukhopadhyay D PY - 2026 JO - Communications medicine DO - 10.1038/s43856-026-01895-x UR - https://doi.org/10.1038/s43856-026-01895-x ER -
APA
RS, A., HK, R., NMR, N., VS, M., P, S., BI, F., T, K., RM, W., S, D., E, W., S, B., K, P., A, Q., & D, M. (2026). Author Correction: Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme.. Communications medicine. https://doi.org/10.1038/s43856-026-01895-x
Source records
- pubmed · retrieved 2026-09-26T07:12:53.335Z